Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

Journal of Comparative Neurology

Volumn 401, Issue 2, 1998, Pages 253-265

  Emborg, Marina E ^a   Ma, Shuang Y ^a   Mufson, Elliott J ^a   Levey, Allan I ^b   Taylor, Michael D ^c   Brown, W Douglas ^c   Holden, James E ^c   Kordower, Jeffrey H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Aging; Dopamine; Motor function; Primates; Stereology; Substantia nigra

Indexed keywords

DOPAMINE TRANSPORTER;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE RELEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RATING SCALE; RHESUS MONKEY; SUBSTANTIA NIGRA;

AGING; ANIMALS; CARRIER PROTEINS; CELL COUNT; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOTOR ACTIVITY; MOTOR NEURONS; NERVE TISSUE PROTEINS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0032538911     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19981116)401:2<253::AID-CNE7>3.0.CO;2-X     Document Type: Article

References (60)

1. Adolfsson, R., B.E. Gottfries Cgm Roos, and B. Winblad (1979) Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural. Transm. 45:81-105.
2. Albert, M.S. (1996) Cognitive and neurobiologic markers of early Alzheimer disease. Proc. Natl. Acad. Sci. USA 93:13547-13551.
3. Bannon, M.J., M.S. Poosch, Y. Xia, D.J. Goebel, B. Cassin, and G. Kapatos (1992) Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. USA 89:7095-7099.
4. Bartus, R.T., R.L. Dean, B. Beer, and A.S. Lippa (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 277:408-417.
5. Bloom, F.E., W.G. Young, E.A. Nimchinsky, P.R. Hof, and J.H. Morrison (1997) Neuronal vulnerability and informatics in human disease. In S.H. Koslow and M.F. Huert (eds): Progress in Neuroinformatics Research, Vol.1, Neuroinformatics - An Overview of the Human Brain Project. Mahwah: Lawrence Erlbaum, pp. 83-123.
6. Bradshaw, J.A. (1994) Age related slowness: Simply strategic? J. Gerontol. 49:133-139.
7. Burns, R.S., C.C. Chiueh, S.P. Markey, M.H. Ebert, D. Jacobowitz, and I.J. Kopin (1983) A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. USA 80:4546-4650.
8. Calne, D.B. and J.W. Langston (1983) Aetiology of Parkinson's disease. Lancet 2:1457-1459.
9. Calne, D.B., E.G. McGeer, A. Eisen, and P.S. Spencer (1986) Alzheimer's disease, Parkinson's disease and motor neuron disease: Abiotrophic interaction between ageing and environment? Lancet 1:1067-1070.
10. Carlsson, A. and B. Winblad (1976) Influence of age and time interval between death and autopsy on dopamine and 3-methotyramine levels in human basal ganglia. J. Neural. Transm. 38:271-276.
11. Ciliax, B.J., C. Heilman, L.L. Demchyshyn, Z.B. Pristupa, E. Ince, S.M. Hersch, H.B. Niznik, and A.I. Levey (1995) The dopamine transporter: Immunochemical characterization and localization in brain. J. Neurosci. 15:1714-1723.
12. Cavalieri, B (1966) Geometric degl: indivisibile. Torino, Unione Tipografico, Editrice pp 1-543.
13. Coggeshall, R.E. (1992) A consideration of neuronal counting methods. Trends Neurosci. 15:9-13.
14. Cohen, G. (1983) The pathophysiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural. Transm. Suppl. 19:89-103.
15. Drucker-Colin, R. and F. Garcia-Hernandez (1991) A new motor test sensitive to aging and dopaminergic function. J. Neurosci. Methods 39:153-161.
16. Elsworth, J.D., A.Y. Deutch, D.E. Redmond, Jr., J.R. Taylor, J.R. Sladek, Jr., and R.H. Roth (1989) Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-treated primates: Biochemical changes in striatal regions. Neuroscience 33:323-331.
17. Fearnley, J.M. and A.J. Lees (1991) Aging and Parkinson's disease: Substantia nigra regional selectivity. Brain 114:2283-2301.
18. Gage, F.H., S.B. Dunnett, and A. Bjorklund (1984) Spatial learning and motor deficits in aged rats. Neurobiol. Aging 5:43-48.
19. Gazzaley, A.H., S.J. Siegel, J.H. Kordower, E.J. Mufson, J.H. Morrison (1996) NMDA receptor-specific alterations within the dendrites of the dentate gyrus in aged macaque monkey. Proc. Natl. Acad. Sci. 93:3121-3125.
20. Gerhardt, G.A., W.A. Cass, M. Henson, Z. Zhang, A. Ovadia, B.J. Hoffer, and D.M. Gash (1995) Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol. Aging 16:939-946.
21. Goldman-Rakic, P.S. and R.M. Brown (1981) Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6:177-187.
22. Gundersen, H.J.G., P. Bagger, T.F. Bendtsen, S.M. Evans, L. Korbo, M. Marcussen, A. Miller, K. Nielsen, J.R. Nyengaard, B. Pakkenberg, F.B. Sorensen, A. Vesterby, and M.J. West (1988) The new stereological tools: Dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
23. Hiral, S. (1968) Ageing of the substantia nigra. Adv. Neurol. Sci. 7:12845-12849.
24. Hornykiewicz, O. (1963) Die Topische Lokalisation und das verhalten von noradrenalin und dopamine (3-hydroxytyramin) in der substantia nigra des normalen und parkinsonkranken menschen. Wein. Klin. Wochenschr. 75:309-312.
25. Irwin, I., L.E. DeLanney, T. McNeill, P. Chan, L. Forno, M.M. Murphy, Jr., D.A. DiMonte, M.S. Sandy, and J.W. Langston (1994) Aging and the nigrostriatal dopamine system: A non-human primate study. Neurode-generation 3:251-265.
26. Irwin, I., K.T. Finnegan, L.E. DeLanney, D.A. DiMonte, and J.W. Langston (1992) The relationships between aging, monoaminooxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: A critical reassessment. Brain Res. 572:224-231.
27. Irwin, I., L.E. DeLanney, and J.W. Langston (1993) MPTP and aging: Studies in the C57BL/6 mouse. In H. Narabayashi, T. Nagatsu, N. Yanagisawa, and Y. Mizuno (eds): Parkinson's Disease: From Basic Research to Treatment. Advances in Neurology, Vol. 60, Proceedings of the 10th International Symposium on Parkinson's Disease. New York: Raven Press, pp. 197-206.
28. Jordan, S., J.L. Eberling, K.S. Bankiewicz, D. Rosenberg, P.G. Coxson, H.F. Van Brocklin, J.P. O'Neil, M.E. Emborg, and W.J. Jagust (1997) 6-[18F]fluoro-L-m-tyrosine: Metabolism, PET kinetics and MPTP lesions in primates. Brain Res. 750:264-276.
29. Kastner, A., E.C. Hirsh, Y. Agid, and F. Javoy Agid (1993) Tyrosine hydroxylase protein and messenger mRNA in dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res. 606:341-345.
30. Koller, W.C., R. O'Hara, W.J. Weiner, A.E. Lang, J.G. Nutt, A.M. Bonnet, and J. Jankovic (1986) Relationship of aging to Parkinson's disease. In M.D. Yahr and K.J. Bergmann (eds): Advances in Neurology. New York: Raven Press, pp. 28-45.
31. Koningsmark, B.W. (1970) Methods for the counting of neurons. In W.J.H. Nauta and S.O.E. Ebbeson (eds): Contemporary Research Methods in Neuroanatomy. New York: Springer-Verlag, pp. 28-45.
32. Kordower, J.H., M.S. Fiandaca, M.F.D. Notter, J.T. Hansen, and D.M. Gash (1990) NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J. Neurosurg. 73:418-428.
33. Kordower, J.H., E. Cochran, R. Penn, C. Goetz (1991) Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol. 29:565-572.
34. Kordower, J.H., Y.-T. Liu, S. Winn, and D.F. Emerich (1995a) Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical and neurochemical analysis. Cell Transplant. 4:155-171.
35. Kordower, J.H., T.B. Freeman, B.J. Snow, F. Vingerhoets, E.J. Mufson, P.R. Sanberg, R.A. Hauser, D.A. Smith, G.M. Nauert, D.P. Perl, and C.W. Olanow (1995b) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124.
36. Kordower, J.H., J.M. Rosenstein, T.J. Collier, M.A. Burke, E.-Y. Chen, J.M. Li, L. Martel, A.E. Levey, E.J. Mufson, T.B. Freeman, and C.W. Olanow (1996) Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomical, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:203-230.
37. Kordower, J.H., E.J. Mufson, N. Fox, L. Martel, and D.F. Emerich (1997) Cellular delivery of NGF does not alter the expression of β amyloid immunoreactivity in young OT aged nonhuman primates. Exp. Neurol. 145:586-591.
38. Kurlan, R., M.H. Kim, and D.M. Gash (1991) Oral levodopa response study in MPTP-induced hemi-parkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism. Mov. Disord. 6:111-118.
39. Lang, A.E., A. Lozano, J. Duff, R. Tasker, J. Miyasaki, N. Galvez-Jimenez, W. Hutchison, and J. Dostrovsky (1997) Medial pallidotomy in latestage Parkinson's disease and striatonigral degeneration. Adv. Neurol. 74:199-211.
40. Langston, J.W., L.S. Forno, C.S. Rebert, and I. Irwin (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropiydine (MPTP) in the squirrel monkeys. Brain Res. 292:390-394.
41. Ma, S.Y., Y. Collan, M. Röyttä, J.O. Rinne, and U.K. Rinne (1995) Cell counts in the substantia nigra: A comparison of single section counts and dissector counts in patients with Parkinson's disease and in controls. Neuropathol. Appl. Neurobiol. 21:10-17.
42. Ma, S.Y. (1997) The substantia nigra in Parkinson's disease: A morphometric study on neuronal changes. Academic thesis, University of Turku, Finland 1-100.
43. Mann, D.M.A. and P.O. Yates (1983) Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech. Ageing Dev. 21:193-203.
44. Marshall, J.F. and A.J. Rosenstein (1990) Age related decline in rat striatal dopamine metabolism is regionally homogeneous. Neurobiol. Aging 11:131-137.
45. McGeer, P.L., E.G. McGeer, and J.S. Suzuki (1977) Aging and extrapyramidal function. Arch. Neurol. 34:33-35.
46. McNeill, T.H. and L.L. Koek (1990) Differential effects of advancing age on neurotransmitter cell loss in the substantia nigra and striatum of C57BL/6N mice. Brain Res. 521:107-117.
47. Mirsky, A.F. and N. Harman (1975) The problem of attention impairment in aging. In G.J. Maletta (ed): Survey Report on the Aging Nervous System. DHEW Publ. # 74-296 NIH, Washington DC, pp. 74-296.
48. Morgan, M., J.G. Phillips, J.L. Bradshaw, J.B. Mattingley, R. Iansek, and J.A. Bradshaw (1994) Age related motor slowness: Simply strategic? J. Gerontol. 49:133-139.
49. Mufson, E.J., W.C. Benzing, D.F. Emerich, J.R. Sladek, Jr., J.H. Morrison, and J.H. Kordower (1994) Apolipoprotein E-immunoreactivity in the aged rhesus monkey cortex: Colocalization with amyloid-containing plaques. Neurobiol. Aging 15:621-627.
50. Mufson, E.J., S. Jaffar, B.J. Ciliax, J. Joyce, D.C. Mash, and A.I. Levey (1997) Dopamine transporter (DAT) immunoreactivity within the human substantia nigra decreases with age. Soc. Neurosci. Abstr. 22:1456.
51. Newman, R.P., P.A. LeWitt, M. Jaffe, D.B. Calne, and T.A. Larsen (1985) Motor function in the normal aging population: Treatment with levodopa. Neurology 35:571-573.
52. Osterburg, H.H., H.G. Donahue, J.A. Severson, and C.E. Finch (1981) Catecholamine levels and turnover during aging in brain regions of male C57BL/6 mice. Brain Res. 224:337-352.
53. Pakkenberg, B., M. Miller, H.J.G. Gundersen, A.M. Dam, and H. Pakkenberg (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 54:30-33.
54. Patlak, C.S. and R.G. Blasberg (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 5:5684-5690.
55. Sladek, J.R. and C.D. Sladek (1979) Relative quantitation of monoamine histofluorescence in young and old non-human primates. In C.E. Finch, D.E. Potter, and A.D. Kenny (eds): Parkinson's Disease II. New York: Plenum Press, pp. 231-239.
56. Ungerstedt, V. (1972) Postsynaptic supersensitivity after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. Suppl. 367:69-93.
57. Van Hartesveldt, C. and J.N. Joyce (1986) Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10:1-14.
58. Walker, L.C., C. Masters, K. Beyreuther, and D.L. Price (1987) Amyloid in the brains of squirrel monkeys. Neurobiol. Aging 8:291-296.
59. Walker, L.C., C. Masters, K. Beyruther, and D.L. Price (1990) Amyloid in the brains of aged squirrel monkeys. Acta. Neuropathol. 80:381-387.
60. West, M.J., K. Ostergaard, O.A. Andreassen, and B. Finsen (1996) Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370:11-22.